Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
about
Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrateThe tuberculosis prodrug isoniazid bound to activating peroxidasesIn vitro antimycobacterial activities of 2'-monosubstituted isonicotinohydrazides and their cyanoborane adducts.Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosisOverexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosisCrystal structure of Mycobacterium tuberculosis catalase-peroxidaseNovel selection for isoniazid (INH) resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistanceTargeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitorsMolecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphismRadiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboonsIsoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activitiesThe susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.Genetic methods for assessing antimicrobial resistance.Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore.Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolatesEvolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patientExploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa.Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosisGenotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazidCharacterization of the MSMEG_2631 gene (mmp) encoding a multidrug and toxic compound extrusion (MATE) family protein in Mycobacterium smegmatis and exploration of its polyspecific nature using biolog phenotype microarray.Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolatesRibosomal mutations promote the evolution of antibiotic resistance in a multidrug environmentInhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains.Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.katGI and katGII encode two different catalases-peroxidases in Mycobacterium fortuitum.Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.
P2860
Q27618301-E32423BC-4F55-4752-A90A-A968D322A460Q27649209-C20A4C6C-020A-4A08-BBBE-4545DCDE7CBFQ28345154-A7113987-1379-4300-9D25-56EE4D68D595Q28379128-F5B7681E-2709-4F86-8E98-1F8CAAF8C5FFQ28486741-F00F85F6-3C40-47C5-A808-85324D7BFC30Q28487119-C18E5B76-C59C-4B2F-BBF2-7222A7403120Q31994689-465374F9-4B8F-4353-9D77-C4E5DC3B61E3Q33292548-375AF5B0-2229-4544-9609-F562F03BCAB1Q33722028-850813CB-5C1A-49C5-99C7-0C351E168280Q33835981-35D3B7E0-AD05-43BD-91E9-BF068FB99AAFQ33836289-AC966B37-AA1C-494B-984B-9BC7A1E2BAC7Q33972028-018941CB-F8B6-4F41-9D2A-1D87EBE694BEQ33975973-ABF320AC-D33D-4F2E-A825-1610C30B5669Q33977528-731434D7-2571-436F-8007-27B7B2D51B3EQ33978473-BEECCC7A-9674-44F6-8778-079C269B0D4BQ33982614-AB1E811E-2F8F-493C-95D9-738366D4DF63Q34230813-9667C99C-8697-4C0D-8B5F-9C79F6A73FB5Q34466858-5DA12A2E-1301-4880-B808-37F4214B7776Q34721919-DE9C00FD-61A2-457B-9290-4B8E95030618Q34973711-896B30BA-377F-491E-A874-646A8D4056E4Q35127110-4E431C4F-D7CD-4490-B055-4D74D8E9279AQ35137375-1BA5717F-6EC0-4BFA-BE24-9D09AF311367Q35545605-4547982E-2614-49CB-ABD9-5B6341F04566Q35909558-93F0C310-68FE-495D-9511-4FB3B94396D3Q36290565-764A70FB-9308-464B-ABA4-809B7D31E466Q36397155-CD8B475B-4CB4-4025-8D58-5C6075E76068Q36543634-118A4B59-7AE9-4B85-8DA6-5C56035CEE80Q36689948-3CC50B90-9236-4220-96BD-941C5F48A0D0Q36760522-91FE6498-0BA1-496F-8503-4CA215497B5EQ37092384-561A7894-6FCD-4974-A5E8-94779F5911EEQ37333132-B8848049-62C5-4117-8C28-1D207907714CQ37656663-5FA7EBCA-B742-4672-95E0-B4CC7F368790Q38019608-EF2A7F86-BDED-47EB-BB81-2320AA6F1FABQ39480174-C5A90605-3C07-4B98-AE07-629EF5D8CC7EQ39665051-C89862B0-074F-48C8-BF4C-245EFF53F03CQ39743333-26190967-38E5-452F-9FA5-148D4AAA759CQ39847830-0450EF7F-2042-4695-84E8-FEFD3B5E13F6Q40282057-F59AAA1C-7C76-48E9-87B9-38444B9DA8F7Q40410540-0A460510-86FF-4606-9CFE-8D1D13B4401AQ41818442-4128D895-EA50-4A75-9008-72405D3BD9B8
P2860
Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Characterization of the katG a ...... of Mycobacterium tuberculosis
@ast
Characterization of the katG a ...... of Mycobacterium tuberculosis
@en
type
label
Characterization of the katG a ...... of Mycobacterium tuberculosis
@ast
Characterization of the katG a ...... of Mycobacterium tuberculosis
@en
prefLabel
Characterization of the katG a ...... of Mycobacterium tuberculosis
@ast
Characterization of the katG a ...... of Mycobacterium tuberculosis
@en
P2093
P2860
P356
P1476
Characterization of the katG a ...... of Mycobacterium tuberculosis
@en
P2093
P2860
P304
P356
10.1128/AAC.39.11.2472
P407
P577
1995-11-01T00:00:00Z